Webinar: Open Call – Prediction of clinical trial outcome in oncology
When: July 18, 2022 6:00 pm
Where: Online
Webinar about AION Labs' Call for Application, titled Prediction of Clinical Trial Outcome in Biomarker-Stratified Cancer Patient Populations

January 8, 2025
Inside AION Labs, the AI-focused venture studio with the backing of AstraZeneca, Pfizer, AWS and other power players

January 1, 2025
Podcast: About Medicines, Innovation and the Future of Biotech with AION Labs CEO (Hebrew)

December 21, 2024
AION Lab’s Promise Bio included in The 51 most disruptive startups of 2024

December 21, 2024
Promise Bio secures $8.3M in seed investment for immune-mediated diseases

December 21, 2024
Promise Bio raises $8.3 million in Seed funding for its precision medicine tool for diseases

November 6, 2024
AION Labs introduces AI startup to hasten identification of active small molecules

February 3, 2024
AION Labs unveils TenAces start-up, will use AI to predict molecular glues

January 30, 2024
AION Labs launches new startup using AI to discover molecular glue therapies

January 8, 2024
Amiti Ventures joins tech.bio venture studio AION Labs as a Strategic Partner

March 1, 2023
Israel lab backed by pharma giants mints startup for computer-designed antibodies

October 7, 2022
Outsourcing Pharma: AION Labs creates AI startup to increase success of drug candidates

September 29, 2022
Q&A: AION Labs’ new startup aims to streamline the drug discovery process

September 28, 2022
Fierce Biotech: Pfizer, AstraZeneca, Merck KGaA-backed Israeli AI incubator launches first biopharma startup

May 2, 2022
Interview with AION Labs CTO: How AL/ML are transforming drug discovery and development

February 15, 2022
AIThority: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

February 14, 2022
AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies

January 19, 2022
Executives Discuss AION Labs, a First-of-its-Kind Innovation Lab Focused on AI Technologies

December 13, 2021
AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

December 13, 2021
AION Labs Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates

October 19, 2021
A partnership between six leading tech and pharma companies wants to create and adopt new AI technologies that could transform the process of drug discovery and development.

October 19, 2021
AION Labs Launches First Global Call for Application: Artificial Intelligence for Antibody Design

October 18, 2021
AION Labs committed to industry best practices business ethics and compliance of IFPMA

October 13, 2021
Pharma Leaders companies join hands with Amazon on new Israel-based AI Innovation Lab

October 13, 2021
AWS joins pharma and biotech leaders in launching AION Labs to transform therapeutics

December 28, 2020